Biomomentum
Provides GLP-compliant biomechanical testing services and manufactures multiaxial mechanical testers for the mechanical characterization of biomaterials, tissues, and cartilage.
- CEO / Founder
- Eric Quenneville, PhD
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $143K
- Latest Round
- Series A
- Key Investors
- Desjardins Capital
Technology & Products
Key Products
Mach-1 multiaxial mechanical tester; Arthro-BST medical device; Mechanical testing services; Customizable testing platforms and accessories
Technological Advantage
Proprietary multiaxial mechanical testing technology validated by hundreds of scientific publications; GLP compliance ensures regulatory acceptance for preclinical testing.
Differentiation
Value Proposition
Enables precise mechanical evaluation and stimulation of soft tissues and biomaterials, supporting research and development in orthopedics, cardiology, and plastic surgery with customizable, high-precision testing solutions.
How They Differentiate
Specializes in multiaxial testing for biomaterials and tissues with higher precision and customization for soft biological materials compared to general-purpose mechanical testers.
Market & Competition
Target Customers
Research scientists, biomedical engineers, orthopedic surgeons, and medical device companies in tissue engineering and regenerative medicine.
Industry Verticals
Medical Devices; Biotechnology; Regenerative Medicine; Tissue Engineering
Competitors
Instron; MTS Systems; Bose ElectroForce
Growth & Milestones
Growth Metrics
Revenue $1 million; 16 employees; 1,316 LinkedIn followers
Major Milestones
Founded in 1999; Winner of 2009 Entrepreneurship & Innovation competition at HEC-Polytechnique-Université de Montréal; Technology commercialization partnership with Polytechnique Montréal